I have to say, when Merck called me last night with the mRNA cancer vaccine news (embargoed, of course), I literally yelped in reaction.
Consider this: Between this spring's Revolution Medicines success with a KRAS-targeted drug and now Merck and Moderna's success with an mRNA neoantigen vaccine, 2026 will go down as one of the most consequential years in cancer treatment, ever.
Incredible.